APA (7th ed.) Citation

Marynissen, H., Buntinx, L., Bamps, D., Depre, M., Ampe, E., Van Hecken, A., . . . de Hoon, J. (2022). First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan. CTS: Clinical & Translational Science, 15(8), 1968. https://doi.org/10.1111/cts.13309

Chicago Style (17th ed.) Citation

Marynissen, Heleen, et al. "First‐in‐human Development of a Pharmacodynamic Biomarker for PAC1 Receptor Antagonists Using Intradermal Injections of Maxadilan." CTS: Clinical & Translational Science 15, no. 8 (2022): 1968. https://doi.org/10.1111/cts.13309.

MLA (9th ed.) Citation

Marynissen, Heleen, et al. "First‐in‐human Development of a Pharmacodynamic Biomarker for PAC1 Receptor Antagonists Using Intradermal Injections of Maxadilan." CTS: Clinical & Translational Science, vol. 15, no. 8, 2022, p. 1968, https://doi.org/10.1111/cts.13309.